George Mclean Milne
Independent Chairman of the BoardDr. George Mclean Milne, Jr., Ph.D., MBA, serves as a Director at Rib-X Pharmaceuticals, Inc. since 2015. He serves as a Director at QTL Inc. since May 24, 2012. He serves as Director and Member of the Scientific Advisory Board at Resolvyx Pharmaceuticals, Inc., which he joined in April 2008. He serves as a Director at BioStorage Technologies, Inc. since August 2006. He serves as a Director at MedImmune, LLC since April 1, 2005. Dr. Milne is an Advisor of Sensorin, Inc. He also serves as a Director at The Mystic Aquarium-Institute for Exploration. Previously, Dr. Milne served as Independent Chairman of the Board at Aurinia Pharmaceuticals Inc. from April 29, 2019 to May 2023 and as a Director from May 9, 2017 to April 29, 2019. He served as Independent Chairman of the Board at Amylyx Pharmaceuticals, Inc. from December 2021 to 2023 and as a Director from 2015 to December 2021. He served as an Independent Director and Independent Lead Director at Charles River Laboratories International, Inc. from 2002 to May 10, 2022. Dr. Milne served as a Director of Mettler-Toledo International Inc. from September 1999 to May 5, 2016. He served as a Director of The Charles Stark Draper Laboratory, Inc. until October 19, 2015. He was an Independent Director at Athersys, Inc. from January 2003 to 2012. He was a Director of Novelion Therapeutics Inc., which he joined on May 24, 2012. He served as a Director of QLT Inc. until May 24, 2012. At Melinta Therapeutics, LLC, he served as Chairman since May 2010, as Executive Chairman from July 2008 to May 2010, and as Director, having joined the company on January 1, 2004. He served as Lead Director at Aspreva International Ltd. since December 2005 and as a Director from September 2004 to 2007. He served as a Director of Conor Medsystems, LLC from October 2003 to 2006. Dr. Milne was a Venture Partner at Radius Ventures, LLC from 2002. At Pfizer Inc., which he joined in 1970, he served as Executive Vice President of Global Research and Development and as President of Worldwide Strategic and Operations Management from 2001 to July 2002, President of Central Research of Pfizer Corporation from 1993 to July 2002, Senior Vice President from 1988, Vice President of Research and Development from 1985 to 1988, Executive Director from 1984 to 1985, and Director of the Department of Immunology and Infectious Diseases from 1981. He has experience in pharmaceutical research and product development. He served as Chairman of Phylogix, Inc. He served as a Director of Sensorin, Inc. He served as a Director of The New York Botanical Garden. He served as a Director of National Foundation for Infectious Diseases. Dr. Milne served as a National Institutes of Health postdoctoral fellow at Stanford University, where he also did Postdoctoral studies in Bio-organic chemistry from 1969 to 1970, and he received postdoctoral training in central nervous system pharmacology at the Medical College of Virginia. He received a Ph.D. in Organic Chemistry from Massachusetts Institute of Technology in 1969 and a B.S. in Chemistry from Yale University in 1965.
Positions
- Company NameAmylyx Pharmaceuticals, Inc.Stock CodeAMLXPositionIndependent Chairman of the BoardColleagues
- JBJoshua B. CohenCo-Founder, Co-CEO & Director
- JBJustin B. KleeCo-CEO & Director
- JMJames M. FratesChief Financial Officer
- CLCamille L. BedrosianChief Medical Officer
- THTom HolmesChief Technical Operations Officer
- RERudolph Emile TanziChairman of The Scientific Advisory Board
- PRPaul R. FonteyneIndependent Director
